NORLUX Neuro-Oncology
NorLux is an international research laboratory in the field of Neuro-Oncology based in two countries, namely Norway and Luxembourg. NorLux represents a state-of-the art research centre with a critical mass of competitive scientists within the three major fields of biomedical research: basic science, translational and clinical research.
NorLux takes advantage of advanced infrastructures and highly developed model systems to reveal the mechanisms behind the initiation and progression of brain tumors.
A strategic agreement was made in 2003, between the Luxembourg Institute of Health (LIH) and the Medical Faculty of the University of Bergen to establish the NorLux Laboratories.
Department of Biomedicine, University of Bergen
Norway
Department of Biomedicine / Rolf Bjerkvig
Jonas Lies vei 91
N-5009 Bergen
Luxembourg Institute of Health
Luxembourg
Department of Oncology / Rolf Bjerkvig
Norlux Neuro-Oncology Laboratory / Simone Niclou
84, Val Fleuri
L-1526 Luxembourg
Latest News & Events :
-
24 May 2018 11h-14h: Lecture Series Cancer Research - "Epigenetics and epigenomics in Health and Diseases" - Prof Francois Fuks
-
Autophagy as potential target against glioblastoma_2018 - 01 - 23
-
Insights into the metabolic disorder in IDH-mutant gliomas_2018 - 01 - 17
-
First CANBIO retreat: kick-off of the Doctoral Training Unit in cancer biology_2017 - 11 - 27
Contact :
-
Head of Department : Prof. Rolf Bjerkvig (Norlux, Norway)
E-mail: rolf.bjerkvig@uib.no
Tel.: + 47 55 58 63 52
-
Head of Unit/Deputy Head of Department : Prof. Simone Niclou (Norlux, Luxembourg)
E-mail: simone.niclou@lih.lu
Tel.: +352 26 970 273
-
Administrative Officer
Siu-Thinh Ho (Norlux, Luxembourg)
Email: siu-thinh.ho@lih.lu
Tel.: +352 26 970 215